Darusentan: An effective endothelinA receptor antagonist for treatment of hypertension
Year: 2002
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: American Journal of Hypertension
Authors: R NAKOV, E PFARR, S EBERLE, HEATINVESTIGATORS
Institution: Abbott (Germany)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: darusentan, endothelin receptor antagonists, hypertension, antihypertensive efficacy, dose-response relationship, adverse events, headache, flushing, peripheral edema, blood pressure reduction, drug safety, endothelin-1, peripheral vasodilation, endothelin-2, endothelin-3, pulmonary arterial hypertension
Open Access status: closed
OpenAlex ID: W1992109588
